Cite
Schulz D, Wirth M, Piontek G, et al. HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substances. Am J Cancer Res. 2016;6(9):1963-1975
Schulz, D., Wirth, M., Piontek, G., Buchberger, A. M., Schlegel, J., Reiter, R., Multhoff, G., & Pickhard, A. (2016). HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substances. American journal of cancer research, 6(9), 1963-1975.
Schulz, Dominik, et al. "HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substances." American journal of cancer research vol. 6,9 (2016): 1963-1975.
Schulz D, Wirth M, Piontek G, Buchberger AM, Schlegel J, Reiter R, Multhoff G, Pickhard A. HNSCC cells resistant to EGFR pathway inhibitors are hypermutated and sensitive to DNA damaging substances. Am J Cancer Res. 2016 Sep 01;6(9):1963-1975. eCollection 2016. PMID: 27725902; PMCID: PMC5043106.
Copy
Download .nbib